MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Validation of a patient-reported functional mobility composite score (FMCS) in people with typical Parkinson’s disease

    AMH. Hanff, A. Rauschenberger, C. Mccrum, G. Aguayo, M. Zeegers, A. Leist, R. Krüger (Strassen, Luxembourg)

    Objective: To investigate the convergent and discriminative validity of a patient-reported FMCS in people with typical PD (PwP). Background: Although a patient-reported instrument is less…
  • 2022 International Congress

    Cognitive and Motor aspects of a Brazilian population with Parkinson´s disease and Impulse Control Disorders and/or Related Behaviors – an observational study.

    B. Veiga, C. da Silva, L. Barcelos, H. Ferraz, S. Silva, V. Borges (São Paulo, Brazil)

    Objective: We analysed if Impulse Control Disorders (ICDs) and/or Related Behaviors (RBs) were associated with levodopa-induced dyskinesia (LIDs) in Brazilian patients with Parkinson´s disease (PD)…
  • 2022 International Congress

    Multimodal MRI assessment of the substantia nigra in premotor and motor stages of parkinsonism

    J. Pasquini, MJ. Firbank, L. Best, V. Foster, V. Silani, G. Petrides, DJ. Brooks, KN. Anderson, N. Pavese (Newcastle upon Tyne, United Kingdom)

    Objective: To investigate substantia nigra (SN) MRI abnormalities through Neuromelanin (NM) and diffusion MRI (dMRI) with Neurite Orientation Dispersion and Density Index (NODDI) in the…
  • 2022 International Congress

    Assessment of novel diffusion MRI metrics of cortical microstructure in the genetic continuum of Parkinson’s disease

    M. Torso, D. Tzaferou, M. Valotti, J. Hardwidge, I. Hardingham, Q. Guo, R. Comley, S. Chance, G. Ridgway (Oxford, United Kingdom)

    Objective: To investigate novel cortical diffusivity metrics in Parkinson’s disease (PD), including both prodromal and established genetic PD, alongside sporadic PD and healthy controls (HC).…
  • 2022 International Congress

    Identifying meaningful symptoms and impacts of disease for patients with early Parkinson’s disease

    J. Mammen, R. Speck, R. Dorsey, M. Müller, P. Yang, S. Jensen-Roberts, M. Kostrzebski, J. Cosman, J. Hellsten, J. Crawford, G. Stebbins, J. Cedarbaum, T. Simuni, T. Dam, K. Ward Barowicz, D. Stephenson, J. Adams (Providence, USA)

    Objective: To explore meaningful symptoms and impacts of disease on daily living in individuals with early-stage Parkinson’s disease (PD). Background: Critical Path for Parkinson’s (CPP)…
  • 2022 International Congress

    Gut dysbiosis in patients with dementia with Lewy bodies

    H. Nishiwaki, M. Ito, T. Hamaguchi, K. Kashihara, T. Maeda, Y. Tsuboi, M. Katsuno, M. Hirayama, K. Ohno (Nagoya, Japan)

    Objective: To identify intestinal bacteria that are changed in DLB alone or in both DLB and cognitive decline in Parkinson’s disease (PD). Background: Gut microbiota…
  • 2022 International Congress

    Cortical oscillatory feature-based classification of Parkinson’s disease with freezing gait

    A. Singh, S. Roy, KC. Santosh (Vermillion, USA)

    Objective: The objective of this study was to determine the resting-state cortical oscillations and the machine learning model that best classifies Parkinson’s disease (PD) patients…
  • 2022 International Congress

    Telemedicine in a Himalayan country: unlocking the barrier in the management of Parkinson’s Disease

    R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari, G. Nepal, J. Yadav, P. Joshi (Kathmandu, Nepal)

    Objective: To evaluate the feasibility of telemedicine among PD patients in Nepal. Background: Nepal is a mountainous country occupying about 85% by Himalayas and hills…
  • 2022 International Congress

    Thalamic white matter macrostructure and subnuclei volumes in Parkinson’s disease depression

    R. Bhome, A. Zarkali, G. Thomas, J. Iglesias, J. Cole, R. Weil (London, United Kingdom)

    Objective: To investigate thalamic subnuclei volume and macrostructural white matter changes in Parkinson’s disease (PD) depression. Background: Depression is a common neuropsychiatric feature of Parkinson’s…
  • 2022 International Congress

    Assessment of non-motor symptoms of Parkinson’s disease in the long-term follow-up after the cell therapy

    V. Chyzhyk, A. Boika, V. Ponomarev (Minsk, Belarus)

    Objective: To evaluate the results of the introduction of MSCs on the non-motor symptoms in patients with PD within 12 months after the cell therapy.…
  • « Previous Page
  • 1
  • …
  • 343
  • 344
  • 345
  • 346
  • 347
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley